Literature DB >> 24909787

Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

Brian P Brennan1, Catherine Lee2, Jason A Elias3, Jesse M Crosby4, Brittany M Mathes4, Marie-Christine Andre5, Christina M Gironda4, Harrison G Pope6, Michael A Jenike3, Garrett M Fitzmaurice7, James I Hudson6.   

Abstract

BACKGROUND: Intensive residential treatment (IRT) is effective for severe, treatment-resistant obsessive-compulsive disorder (OCD). We sought to characterize predictors and course of response to IRT.
METHODS: Admission, monthly, and discharge data were collected on individuals receiving IRT. We examined the association between baseline characteristics and percent change in OCD symptoms as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) using linear regression. We compared baseline characteristics of IRT responders (≥35% reduction in Y-BOCS) versus non-responders, and of patients who did versus those who did not achieve wellness (Y-BOCS ≤ 12) using non-parametric tests. To examine the course of OCD severity over time, we used linear mixed-effects models with randomly varying intercepts and slopes.
RESULTS: We evaluated 281 individuals admitted to an IRT program. Greater baseline Y-BOCS scores were associated with a significantly greater percent reduction in Y-BOCS scores (β = -1.49 ([95% confidence interval: -2.06 to -0.93]; P < .001)). IRT responders showed significantly greater baseline Y-BOCS scores than non-responders (mean (SD) 28 (5.2) vs. 25.6 (5.8); P = .003) and lower past-year alcohol use scores than non-responders (1.4 (1.9) vs. 2.1 (2.2); P = .01). Participants who achieved wellness displayed lower hoarding factor scores than those who did not (5 (4.6) vs. 9.53 (6.3); P = .03). OCD symptoms declined rapidly over the first month but more slowly over the remaining two months.
CONCLUSIONS: Higher baseline OCD severity, lower past-year alcohol use, and fewer hoarding symptoms predicted better response to IRT. IRT yielded an initial rapid reduction in OCD symptoms, followed by a slower decline after the first month.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hoarding; IRT; Intensive residential treatment; OCD; Obsessive-compulsive disorder; Predictors

Mesh:

Year:  2014        PMID: 24909787      PMCID: PMC4112460          DOI: 10.1016/j.jpsychires.2014.05.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  42 in total

1.  Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Authors:  Raşit Tükel; Oya Bozkurt; Aslihan Polat; Aysun Genç; Hatice Atli
Journal:  Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.188

2.  Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome.

Authors:  M Rufer; S Fricke; S Moritz; M Kloss; I Hand
Journal:  Acta Psychiatr Scand       Date:  2006-05       Impact factor: 6.392

3.  Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder.

Authors:  Eric A Storch; Michael J Larson; Nathan A Shapira; Herbert E Ward; Tanya K Murphy; Gary R Geffken; Holly Valerio; Wayne K Goodman
Journal:  Depress Anxiety       Date:  2006       Impact factor: 6.505

4.  Treatment of severe, treatment-refractory obsessive-compulsive disorder: a study of inpatient and community treatment.

Authors:  Mark J Boschen; Lynne M Drummond; Anusha Pillay
Journal:  CNS Spectr       Date:  2008-12       Impact factor: 3.790

5.  Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting.

Authors:  Thröstur Björgvinsson; Chad T Wetterneck; Dana M Powell; Gregory S Chasson; Sarah A Webb; John Hart; Susan Heffelfinger; Renee Azzouz; Terri L Entricht; Joyce E Davidson; Melinda A Stanley
Journal:  J Psychiatr Pract       Date:  2008-05       Impact factor: 1.325

6.  Meta-analysis of the symptom structure of obsessive-compulsive disorder.

Authors:  Michael H Bloch; Angeli Landeros-Weisenberger; Maria C Rosario; Christopher Pittenger; James F Leckman
Journal:  Am J Psychiatry       Date:  2008-10-15       Impact factor: 18.112

Review 7.  Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder.

Authors:  Mary L Keeley; Eric A Storch; Lisa J Merlo; Gary R Geffken
Journal:  Clin Psychol Rev       Date:  2007-04-29

8.  D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

Authors:  Matt G Kushner; Suck Won Kim; Christopher Donahue; Paul Thuras; David Adson; Michael Kotlyar; James McCabe; Jillian Peterson; Edna B Foa
Journal:  Biol Psychiatry       Date:  2007-06-22       Impact factor: 13.382

9.  Cognitive-behavioral therapy for obsessive-compulsive disorder: a non-randomized comparison of intensive and weekly approaches.

Authors:  Eric A Storch; Lisa J Merlo; Heather Lehmkuhl; Gary R Geffken; Marni Jacob; Emily Ricketts; Tanya K Murphy; Wayne K Goodman
Journal:  J Anxiety Disord       Date:  2007-12-23

10.  Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.

Authors:  Sabine Wilhelm; Ulrike Buhlmann; David F Tolin; Suzanne A Meunier; Godfrey D Pearlson; Hannah E Reese; Paul Cannistraro; Michael A Jenike; Scott L Rauch
Journal:  Am J Psychiatry       Date:  2008-02-01       Impact factor: 18.112

View more
  6 in total

1.  An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Authors:  Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2015-02-09       Impact factor: 7.853

2.  Long-term Outcomes of Intensive Inpatient Care for Severe, Resistant Obsessive-Compulsive Disorder: Résultats à long terme de soins intensifs à des patients hospitalisés pour un trouble obsessionnel-compulsif grave et résistant.

Authors:  Srinivas Balachander; Aakash Bajaj; Nandita Hazari; Ajay Kumar; Nitin Anand; M Manjula; Paulomi M Sudhir; Anish V Cherian; Janardhanan C Narayanaswamy; T S Jaisoorya; Suresh Bada Math; Thennarasu Kandavel; Shyam Sundar Arumugham; Y C Janardhan Reddy
Journal:  Can J Psychiatry       Date:  2020-05-26       Impact factor: 4.356

3.  LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

Authors:  Brian P Brennan; J Eric Jensen; Christine Perriello; Harrison G Pope; Michael A Jenike; James I Hudson; Scott L Rauch; Marc J Kaufman
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-02-01

4.  Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Brian P Brennan; Lorrin Koran; Carol A Mathews; Gerald Nestadt; Michele Pato; Katharine A Phillips; Carolyn I Rodriguez; H Blair Simpson; Petros Skapinakis; Dan J Stein; Eric A Storch
Journal:  Psychiatry Res       Date:  2021-03-04       Impact factor: 11.225

5.  Change in obsessive beliefs as predictor and mediator of symptom change during treatment of obsessive-compulsive disorder - a process-outcome study.

Authors:  Alice Diedrich; Philipp Sckopke; Caroline Schwartz; Sandra Schlegl; Bernhard Osen; Christian Stierle; Ulrich Voderholzer
Journal:  BMC Psychiatry       Date:  2016-07-07       Impact factor: 3.630

6.  Predictors of Intensive Treatment in Patients With Obsessive-Compulsive Disorder.

Authors:  Johanna A M du Mortier; Karin C P Remmerswaal; Neeltje M Batelaan; Henny A D Visser; Jos W R Twisk; Patricia van Oppen; Anton J L M van Balkom
Journal:  Front Psychiatry       Date:  2021-04-12       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.